Global DNA/RNA Extraction Kit Market By Type (Total RNA, Cell-free DNA, Viral DNA/RNA, Purified RNA, Sequence-Specific DNA/RNA, Others); By Format (Automated, Manual); By Kit Size (Miniprep, Midiprep, Maxiprep, Others); By Sample Type (Blood, Nasal Swabs, Tissues, Saliva, Serum and Plasma, Stool, Cerebral Fluid, Others); By Application (cDNA Synthesis, Cloning, Real Time PCR, Microarray Analysis, Next-Generation Sequencing, Northern Blot Analysis, Pathogen Detection, Others); By End User (Hospitals, Laboratories, Others); By Sales Channel (Direct, Indirect); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027

Report ID :AMI-680 | Category : Healthcare | Published Date : September, 2020 | Pages : 402 | Format :PDF

Industry Trends

The growing prevalence of chronic illnesses across global population has fuelled the demand of DNA/RNA extraction kits for diagnosis and treatment purposes.

The growing urbanisation has pushed people to adopt a sedentary lifestyle which is leading to rising occurance of chronic diseases. World Health Organization states that chronic condition rates are accelerating globally, and is anticipated to contribute 60% of the total burden of disease by 2020. These growing number of patients with chronic disease such as cardiovascular diseases, cancer, obesity, diabetes and others have fuelled the demand for health care treatments. Study of the patient before giving any treatment is necessary to pre-determine the consequences. For instance, nucleic acids such as DNA and RNA are extracted to perform medical investigation of a patient suffering from cancer. It assists to develop in-depth understanding of tumor genetics, mutation analysis, microsatellite analysis, and comparative genomic hybridization. The purity, quantity, and quality of extracted DNA or RNA plays a significant role in the success thus, creating demand for extraction kits to effectively and precisely isolate nucleic acids from samples. The DNA/ RNA extraction kit provides a simple, nontoxic method for efficiently isolating high-molecular-weight DNA or RNA from tissue, whole blood and cultured cells. The DNA/ RNA extraction kits of BioVision Inc. facilitate identification of tumor miRNA or mRNAs signatures from human biological fluids. Along with chronic illnesses, the rise in number of infectious diseases is further propelling the demand of DNA/RNA extraction kits for pathogen detection, antigen testing and other such purposes. Thus, the growing number of diseases is fuelling the demand in global DNA/RNA extraction kit market.

Growing range of applications is another driver propelling the demand in global DNA/RNA extraction kit market. Along with medical science, biology and other fields of application, these nucleic acid extraction kits are also being used in forensics for investigation of crime scene. Crime scene evidence comprises of a multitude of samples containing biological fluids and tissues such as human blood, semen, saliva, epithelial cells, hair, bone, teeth, fingernails, cigarette butts, stamps, and tissues. These samples need to be processed using the most effective methods of nucleic acid extraction and purification for downstream quantification and genetic profiling. DNA extraction kits are used to extract DNA from samples for forensic testing purposes. Market players such as Thermo Fisher Scientific Inc., GeneON GmbH, Takara Bio Inc. and many others provide dedicated DNA extraction kits for forensic applications. Thus, the growing demand from forensic science is driving the propelling the DNA/RNA extraction kit market across the globe.

The cost of DNA/RNA extraction kits has led to low levels of product penetration in under-developed markets which impedes the market growth. In order to overcome this challenge, market players are incorporating advanced technologies in these kits which increases their efficiency and reduces cost. For instance, in June 2020, Lexogen GmbH launched TraPR kit for gel free extraction of small RNA which enables accurate, reproducible and cost-effective analysis of RNA. This rising investment in research and development of DNA/RNA extraction kit to develop low cost, user friendly solutions are anticipated to boost the growth of global DNA/RNA extraction kit market in forecast years.

SARS-CoV-2 is a single-stranded RNA virus. The structure of coronavirus (SARS-CoV-2) consists of a spike protein, hemagglutinin-esterease dimer, a membrane glycoprotein, an envelope protein, a nucleoclapid protein and RNA. The accurate and sensitive detection of coronavirus infection requires isolation of viral RNA from the sample. This process has inflated the demand for manual as well as automated RNA extraction kits from diagnosticians, vaccine manufacturers and researchers across the globe. Owing to this rise in demand, many market players are introducing a wide range of product offerings. For instance, Omega Bio-tek, Inc. launched Mag-Bind Viral RNA Xpress Kit in June 2020 for isolation of viral RNA. Similarly, Takara Bio Inc., Agappediagnostics, PHASE SCIENTIFIC INTERNATIONAL LTD and others have also introduced dedicated viral RNA extraction kits for COVID-19. Thus, the high demand from medical professionals and researchers to control the spread of COVID-19 pandemic is anticipated to fuel the growth of global DNA/RNA extraction kit market.

Format Outlook:

Concerns related to usage of manual DNA/RNA extraction kits such as time-consuming, low sensitivity and specificity are creating high demand for automated extraction kits. The increasing use of molecular diagnostics in medical as well as other fields has resulted in increased numbers of specimens submitted to clinical laboratories which has necessitated automation of the DNA/RNA extraction kits. The recent outbreak of COVID-19 pandemic has further contributed to the growing popularity of automated kits. These kits have twice as much output than manual ones, hence are used to test high flow of COVID-19 samples. For instance, BIOTECON Diagnostics GmbH launched a fully automatic DNA extraction kit based on magnetic bead technology for detecting COVID-19 in April 2020. This kit permits a through-put of 94 patient samples per 90 minutes. Thus, as governments are focusing on increasing their testing rates to identify positive patients and limit the spread of coronavirus, the market share of automated format is anticipated to witness high growth rate in global DNA/RNA extraction kit market.

Application Outlook:

Molecular cloning is gaining high popularity in clinical microbiology. The extraction of a particular gene or DNA sequence for production of its exact copies is called cloning. Recombinant antigens produced by cloning techniques are being used for screening of clinical infectious agents. Recombinant vaccines for hepatitis B, cholera and other diseases also use recombinant antigens. Cloning is also being used for early detection of hereditary diseases, forensic investigations and routine diagnosis. Market players such as Creative Biogene, Takara Bio Inc., Bio-Rad Laboratories, Inc. and others provide DNA extraction kits for cloning applications. Thus, the growing application of cloning in wide array of fields is driving its share in global DNA/RNA extraction kit market.

Regional Outlook:

North America region registered the highest share in global DNA/RNA extraction kit market in 2018. However, the Asia Pacific region is anticipated to witness high growth rate over forecast years owing to the rise in demand from pharmaceutical industry. The pharmaceutical industry in Asia Pacific region is rapidly growing. Laboratories of pharmaceutical companies use DNA/RNA extraction kits for conducting clinical trials, ensuring product safety and other purposes. Thus, the flourishing pharmaceutical industry in the countries such as China, India and other Asia Pacific countries is expected to create high demand for the nucleic acid extraction kits, thus propelling the share of Asia Pacific region in global DNA/RNA extraction kit market over forecast period.

In terms of revenue, global DNA/RNA extraction kit market was valued at US$ 586.56 Mn in 2018 and is anticipated to grow at a CAGR of 6.8% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global DNA/RNA Extraction Kit Market Revenue & Forecast, (US$ Million), 2015 – 2027

Competitive Landscape

The report provides both, qualitative and quantitative research of DNA/RNA extraction kit market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the DNA/RNA extraction kit market are Agilent Technologies, Inc., Akonni Biosystems, Inc., Beckman Coulter, Inc., BIOFIRE DIAGONOSTIC, INC., Bioneer Corporation, Bio-Rad Laboratories, Inc., Canvax Biotech S.L., Hunan Runmei Gene Technology Co., LTD, Krishgen Biosystems, Lexogen GmbH, Primerdesign Ltd., Promega Corporation, QIAGEN, Swagene, Takara Bio Inc, TaigenBioscience Corporation and Thermo Fisher Scientific Inc. amongst others.

Click on image to enlarge

Global DNA/RNA Extraction Kit Market:

By Type

Total RNA
Cell-free DNA
Viral DNA/RNA
Purified RNA
Sequence-Specific DNA/RNA
Others

By Format

Automated
Manual

By Kit Size

Miniprep
Midiprep
Maxiprep
Others

By Sample Type

Blood
Nasal Swabs
Tissues
Saliva
Serum and Plasma
Stool
Cerebral Fluid
Others

By Application

cDNA Synthesis
Cloning
Real Time PCR
Microarray Analysis
Next-Generation Sequencing
Northern Blot Analysis
Pathogen Detection
Others

By End User

Hospitals
Laboratories
Others

By Sales Channel

Direct
Indirect

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
- Rest of Asia Pacific
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of DNA/RNA Extraction Kit Market

6. Market Synopsis: DNA/RNA Extraction Kit Market

7. DNA/RNA Extraction Kit Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in DNA/RNA Extraction Kit Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: DNA/RNA Extraction Kit Market

7.6. Porter’s Five Force Analysis

7.7. Analysis on Impact of Covid-19 on Global DNA/RNA Extraction Kit Market

8. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn)

8.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

8.2.1. Total RNA

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2013 – 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2013 – 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2013 – 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2013 – 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2013 – 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2013 – 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. Cell-free DNA

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2013 – 2018

8.2.2.3. Market Forecast, 2019 – 2027

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2013 – 2018

8.2.2.5.1.2. Market Forecast, 2019 – 2027

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2013 – 2018

8.2.2.5.2.2. Market Forecast, 2019 – 2027

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2013 – 2018

8.2.2.5.3.2. Market Forecast, 2019 – 2027

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2013 – 2018

8.2.2.5.4.2. Market Forecast, 2019 – 2027

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2013 – 2018

8.2.2.5.5.2. Market Forecast, 2019 – 2027

8.2.3. Viral DNA/RNA

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2013 – 2018

8.2.3.3. Market Forecast, 2019 – 2027

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2013 – 2018

8.2.3.5.1.2. Market Forecast, 2019 – 2027

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2013 – 2018

8.2.3.5.2.2. Market Forecast, 2019 – 2027

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2013 – 2018

8.2.3.5.3.2. Market Forecast, 2019 – 2027

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2013 – 2018

8.2.3.5.4.2. Market Forecast, 2019 – 2027

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2013 – 2018

8.2.3.5.5.2. Market Forecast, 2019 – 2027

8.2.4. Purified RNA

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2013 – 2018

8.2.4.3. Market Forecast, 2019 – 2027

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2013 – 2018

8.2.4.5.1.2. Market Forecast, 2019 – 2027

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2013 – 2018

8.2.4.5.2.2. Market Forecast, 2019 – 2027

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2013 – 2018

8.2.4.5.3.2. Market Forecast, 2019 – 2027

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2013 – 2018

8.2.4.5.4.2. Market Forecast, 2019 – 2027

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2013 – 2018

8.2.4.5.5.2. Market Forecast, 2019 – 2027

8.2.5. Sequence-Specific DNA/RNA

8.2.5.1. Definition

8.2.5.2. Market Estimation and Penetration, 2013 – 2018

8.2.5.3. Market Forecast, 2019 – 2027

8.2.5.4. Compound Annual Growth Rate (CAGR)

8.2.5.5. Regional Bifurcation

8.2.5.5.1. North America

8.2.5.5.1.1. Market Estimation, 2013 – 2018

8.2.5.5.1.2. Market Forecast, 2019 – 2027

8.2.5.5.2. Europe

8.2.5.5.2.1. Market Estimation, 2013 – 2018

8.2.5.5.2.2. Market Forecast, 2019 – 2027

8.2.5.5.3. Asia Pacific

8.2.5.5.3.1. Market Estimation, 2013 – 2018

8.2.5.5.3.2. Market Forecast, 2019 – 2027

8.2.5.5.4. Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2013 – 2018

8.2.5.5.4.2. Market Forecast, 2019 – 2027

8.2.5.5.5. Latin America

8.2.5.5.5.1. Market Estimation, 2013 – 2018

8.2.5.5.5.2. Market Forecast, 2019 – 2027

8.2.6. Others

8.2.6.1. Definition

8.2.6.2. Market Estimation and Penetration, 2013 – 2018

8.2.6.3. Market Forecast, 2019 – 2027

8.2.6.4. Compound Annual Growth Rate (CAGR)

8.2.6.5. Regional Bifurcation

8.2.6.5.1. North America

8.2.6.5.1.1. Market Estimation, 2013 – 2018

8.2.6.5.1.2. Market Forecast, 2019 – 2027

8.2.6.5.2. Europe

8.2.6.5.2.1. Market Estimation, 2013 – 2018

8.2.6.5.2.2. Market Forecast, 2019 – 2027

8.2.6.5.3. Asia Pacific

8.2.6.5.3.1. Market Estimation, 2013 – 2018

8.2.6.5.3.2. Market Forecast, 2019 – 2027

8.2.6.5.4. Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2013 – 2018

8.2.6.5.4.2. Market Forecast, 2019 – 2027

8.2.6.5.5. Latin America

8.2.6.5.5.1. Market Estimation, 2013 – 2018

8.2.6.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Type

9. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

9.2.1. Automated

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2013 – 2018

9.2.1.3. Market Forecast, 2019 – 2027

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2013 – 2018

9.2.1.5.1.2. Market Forecast, 2019 – 2027

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2013 – 2018

9.2.1.5.2.2. Market Forecast, 2019 – 2027

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2013 – 2018

9.2.1.5.3.2. Market Forecast, 2019 – 2027

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2013 – 2018

9.2.1.5.4.2. Market Forecast, 2019 – 2027

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2013 – 2018

9.2.1.5.5.2. Market Forecast, 2019 – 2027

9.2.2. Manual

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2013 – 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2013 – 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2013 – 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2013 – 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2013 – 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2013 – 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Format

10. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

10.2.1. Miniprep

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2013 – 2018

10.2.1.3. Market Forecast, 2019 – 2027

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2013 – 2018

10.2.1.5.1.2. Market Forecast, 2019 – 2027

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2013 – 2018

10.2.1.5.2.2. Market Forecast, 2019 – 2027

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2013 – 2018

10.2.1.5.3.2. Market Forecast, 2019 – 2027

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2013 – 2018

10.2.1.5.4.2. Market Forecast, 2019 – 2027

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2013 – 2018

10.2.1.5.5.2. Market Forecast, 2019 – 2027

10.2.2. Midiprep

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2013 – 2018

10.2.2.3. Market Forecast, 2019 – 2027

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2013 – 2018

10.2.2.5.1.2. Market Forecast, 2019 – 2027

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2013 – 2018

10.2.2.5.2.2. Market Forecast, 2019 – 2027

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2013 – 2018

10.2.2.5.3.2. Market Forecast, 2019 – 2027

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2013 – 2018

10.2.2.5.4.2. Market Forecast, 2019 – 2027

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2013 – 2018

10.2.2.5.5.2. Market Forecast, 2019 – 2027

10.2.3. Maxiprep

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2013 – 2018

10.2.3.3. Market Forecast, 2019 – 2027

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2013 – 2018

10.2.3.5.1.2. Market Forecast, 2019 – 2027

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2013 – 2018

10.2.3.5.2.2. Market Forecast, 2019 – 2027

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2013 – 2018

10.2.3.5.3.2. Market Forecast, 2019 – 2027

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2013 – 2018

10.2.3.5.4.2. Market Forecast, 2019 – 2027

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2013 – 2018

10.2.3.5.5.2. Market Forecast, 2019 – 2027

10.2.4. Others

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2013 – 2018

10.2.4.3. Market Forecast, 2019 – 2027

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2013 – 2018

10.2.4.5.1.2. Market Forecast, 2019 – 2027

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2013 – 2018

10.2.4.5.2.2. Market Forecast, 2019 – 2027

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2013 – 2018

10.2.4.5.3.2. Market Forecast, 2019 – 2027

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2013 – 2018

10.2.4.5.4.2. Market Forecast, 2019 – 2027

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2013 – 2018

10.2.4.5.5.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By Kit Size

11. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

11.1. Overview

11.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

11.2.1. Blood

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2013 – 2018

11.2.1.3. Market Forecast, 2019 – 2027

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2013 – 2018

11.2.1.5.1.2. Market Forecast, 2019 – 2027

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2013 – 2018

11.2.1.5.2.2. Market Forecast, 2019 – 2027

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2013 – 2018

11.2.1.5.3.2. Market Forecast, 2019 – 2027

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2013 – 2018

11.2.1.5.4.2. Market Forecast, 2019 – 2027

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2013 – 2018

11.2.1.5.5.2. Market Forecast, 2019 – 2027

11.2.2. Nasal Swabs

11.2.2.1. Definition

11.2.2.2. Market Estimation and Penetration, 2013 – 2018

11.2.2.3. Market Forecast, 2019 – 2027

11.2.2.4. Compound Annual Growth Rate (CAGR)

11.2.2.5. Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2013 – 2018

11.2.2.5.1.2. Market Forecast, 2019 – 2027

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2013 – 2018

11.2.2.5.2.2. Market Forecast, 2019 – 2027

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2013 – 2018

11.2.2.5.3.2. Market Forecast, 2019 – 2027

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2013 – 2018

11.2.2.5.4.2. Market Forecast, 2019 – 2027

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2013 – 2018

11.2.2.5.5.2. Market Forecast, 2019 – 2027

11.2.3. Tissues

11.2.3.1. Definition

11.2.3.2. Market Estimation and Penetration, 2013 – 2018

11.2.3.3. Market Forecast, 2019 – 2027

11.2.3.4. Compound Annual Growth Rate (CAGR)

11.2.3.5. Regional Bifurcation

11.2.3.5.1. North America

11.2.3.5.1.1. Market Estimation, 2013 – 2018

11.2.3.5.1.2. Market Forecast, 2019 – 2027

11.2.3.5.2. Europe

11.2.3.5.2.1. Market Estimation, 2013 – 2018

11.2.3.5.2.2. Market Forecast, 2019 – 2027

11.2.3.5.3. Asia Pacific

11.2.3.5.3.1. Market Estimation, 2013 – 2018

11.2.3.5.3.2. Market Forecast, 2019 – 2027

11.2.3.5.4. Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2013 – 2018

11.2.3.5.4.2. Market Forecast, 2019 – 2027

11.2.3.5.5. Latin America

11.2.3.5.5.1. Market Estimation, 2013 – 2018

11.2.3.5.5.2. Market Forecast, 2019 – 2027

11.2.4. Saliva

11.2.4.1. Definition

11.2.4.2. Market Estimation and Penetration, 2013 – 2018

11.2.4.3. Market Forecast, 2019 – 2027

11.2.4.4. Compound Annual Growth Rate (CAGR)

11.2.4.5. Regional Bifurcation

11.2.4.5.1. North America

11.2.4.5.1.1. Market Estimation, 2013 – 2018

11.2.4.5.1.2. Market Forecast, 2019 – 2027

11.2.4.5.2. Europe

11.2.4.5.2.1. Market Estimation, 2013 – 2018

11.2.4.5.2.2. Market Forecast, 2019 – 2027

11.2.4.5.3. Asia Pacific

11.2.4.5.3.1. Market Estimation, 2013 – 2018

11.2.4.5.3.2. Market Forecast, 2019 – 2027

11.2.4.5.4. Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2013 – 2018

11.2.4.5.4.2. Market Forecast, 2019 – 2027

11.2.4.5.5. Latin America

11.2.4.5.5.1. Market Estimation, 2013 – 2018

11.2.4.5.5.2. Market Forecast, 2019 – 2027

11.2.5. Serum and Plasma

11.2.5.1. Definition

11.2.5.2. Market Estimation and Penetration, 2013 – 2018

11.2.5.3. Market Forecast, 2019 – 2027

11.2.5.4. Compound Annual Growth Rate (CAGR)

11.2.5.5. Regional Bifurcation

11.2.5.5.1. North America

11.2.5.5.1.1. Market Estimation, 2013 – 2018

11.2.5.5.1.2. Market Forecast, 2019 – 2027

11.2.5.5.2. Europe

11.2.5.5.2.1. Market Estimation, 2013 – 2018

11.2.5.5.2.2. Market Forecast, 2019 – 2027

11.2.5.5.3. Asia Pacific

11.2.5.5.3.1. Market Estimation, 2013 – 2018

11.2.5.5.3.2. Market Forecast, 2019 – 2027

11.2.5.5.4. Middle East and Africa

11.2.5.5.4.1. Market Estimation, 2013 – 2018

11.2.5.5.4.2. Market Forecast, 2019 – 2027

11.2.5.5.5. Latin America

11.2.5.5.5.1. Market Estimation, 2013 – 2018

11.2.5.5.5.2. Market Forecast, 2019 – 2027

11.2.6. Stool

11.2.6.1. Definition

11.2.6.2. Market Estimation and Penetration, 2013 – 2018

11.2.6.3. Market Forecast, 2019 – 2027

11.2.6.4. Compound Annual Growth Rate (CAGR)

11.2.6.5. Regional Bifurcation

11.2.6.5.1. North America

11.2.6.5.1.1. Market Estimation, 2013 – 2018

11.2.6.5.1.2. Market Forecast, 2019 – 2027

11.2.6.5.2. Europe

11.2.6.5.2.1. Market Estimation, 2013 – 2018

11.2.6.5.2.2. Market Forecast, 2019 – 2027

11.2.6.5.3. Asia Pacific

11.2.6.5.3.1. Market Estimation, 2013 – 2018

11.2.6.5.3.2. Market Forecast, 2019 – 2027

11.2.6.5.4. Middle East and Africa

11.2.6.5.4.1. Market Estimation, 2013 – 2018

11.2.6.5.4.2. Market Forecast, 2019 – 2027

11.2.6.5.5. Latin America

11.2.6.5.5.1. Market Estimation, 2013 – 2018

11.2.6.5.5.2. Market Forecast, 2019 – 2027

11.2.7. Cerebral Fluid

11.2.7.1. Definition

11.2.7.2. Market Estimation and Penetration, 2013 – 2018

11.2.7.3. Market Forecast, 2019 – 2027

11.2.7.4. Compound Annual Growth Rate (CAGR)

11.2.7.5. Regional Bifurcation

11.2.7.5.1. North America

11.2.7.5.1.1. Market Estimation, 2013 – 2018

11.2.7.5.1.2. Market Forecast, 2019 – 2027

11.2.7.5.2. Europe

11.2.7.5.2.1. Market Estimation, 2013 – 2018

11.2.7.5.2.2. Market Forecast, 2019 – 2027

11.2.7.5.3. Asia Pacific

11.2.7.5.3.1. Market Estimation, 2013 – 2018

11.2.7.5.3.2. Market Forecast, 2019 – 2027

11.2.7.5.4. Middle East and Africa

11.2.7.5.4.1. Market Estimation, 2013 – 2018

11.2.7.5.4.2. Market Forecast, 2019 – 2027

11.2.7.5.5. Latin America

11.2.7.5.5.1. Market Estimation, 2013 – 2018

11.2.7.5.5.2. Market Forecast, 2019 – 2027

11.2.8. Others

11.2.8.1. Definition

11.2.8.2. Market Estimation and Penetration, 2013 – 2018

11.2.8.3. Market Forecast, 2019 – 2027

11.2.8.4. Compound Annual Growth Rate (CAGR)

11.2.8.5. Regional Bifurcation

11.2.8.5.1. North America

11.2.8.5.1.1. Market Estimation, 2013 – 2018

11.2.8.5.1.2. Market Forecast, 2019 – 2027

11.2.8.5.2. Europe

11.2.8.5.2.1. Market Estimation, 2013 – 2018

11.2.8.5.2.2. Market Forecast, 2019 – 2027

11.2.8.5.3. Asia Pacific

11.2.8.5.3.1. Market Estimation, 2013 – 2018

11.2.8.5.3.2. Market Forecast, 2019 – 2027

11.2.8.5.4. Middle East and Africa

11.2.8.5.4.1. Market Estimation, 2013 – 2018

11.2.8.5.4.2. Market Forecast, 2019 – 2027

11.2.8.5.5. Latin America

11.2.8.5.5.1. Market Estimation, 2013 – 2018

11.2.8.5.5.2. Market Forecast, 2019 – 2027

11.3. Key Segment for Channeling Investments

11.3.1. By Sample Type

12. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

12.1. Overview

12.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

12.2.1. cDNA Synthesis

12.2.1.1. Definition

12.2.1.2. Market Estimation and Penetration, 2013 – 2018

12.2.1.3. Market Forecast, 2019 – 2027

12.2.1.4. Compound Annual Growth Rate (CAGR)

12.2.1.5. Regional Bifurcation

12.2.1.5.1. North America

12.2.1.5.1.1. Market Estimation, 2013 – 2018

12.2.1.5.1.2. Market Forecast, 2019 – 2027

12.2.1.5.2. Europe

12.2.1.5.2.1. Market Estimation, 2013 – 2018

12.2.1.5.2.2. Market Forecast, 2019 – 2027

12.2.1.5.3. Asia Pacific

12.2.1.5.3.1. Market Estimation, 2013 – 2018

12.2.1.5.3.2. Market Forecast, 2019 – 2027

12.2.1.5.4. Middle East and Africa

12.2.1.5.4.1. Market Estimation, 2013 – 2018

12.2.1.5.4.2. Market Forecast, 2019 – 2027

12.2.1.5.5. Latin America

12.2.1.5.5.1. Market Estimation, 2013 – 2018

12.2.1.5.5.2. Market Forecast, 2019 – 2027

12.2.2. Cloning

12.2.2.1. Definition

12.2.2.2. Market Estimation and Penetration, 2013 – 2018

12.2.2.3. Market Forecast, 2019 – 2027

12.2.2.4. Compound Annual Growth Rate (CAGR)

12.2.2.5. Regional Bifurcation

12.2.2.5.1. North America

12.2.2.5.1.1. Market Estimation, 2013 – 2018

12.2.2.5.1.2. Market Forecast, 2019 – 2027

12.2.2.5.2. Europe

12.2.2.5.2.1. Market Estimation, 2013 – 2018

12.2.2.5.2.2. Market Forecast, 2019 – 2027

12.2.2.5.3. Asia Pacific

12.2.2.5.3.1. Market Estimation, 2013 – 2018

12.2.2.5.3.2. Market Forecast, 2019 – 2027

12.2.2.5.4. Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2013 – 2018

12.2.2.5.4.2. Market Forecast, 2019 – 2027

12.2.2.5.5. Latin America

12.2.2.5.5.1. Market Estimation, 2013 – 2018

12.2.2.5.5.2. Market Forecast, 2019 – 2027

12.2.3. Real Time PCR

12.2.3.1. Definition

12.2.3.2. Market Estimation and Penetration, 2013 – 2018

12.2.3.3. Market Forecast, 2019 – 2027

12.2.3.4. Compound Annual Growth Rate (CAGR)

12.2.3.5. Regional Bifurcation

12.2.3.5.1. North America

12.2.3.5.1.1. Market Estimation, 2013 – 2018

12.2.3.5.1.2. Market Forecast, 2019 – 2027

12.2.3.5.2. Europe

12.2.3.5.2.1. Market Estimation, 2013 – 2018

12.2.3.5.2.2. Market Forecast, 2019 – 2027

12.2.3.5.3. Asia Pacific

12.2.3.5.3.1. Market Estimation, 2013 – 2018

12.2.3.5.3.2. Market Forecast, 2019 – 2027

12.2.3.5.4. Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2013 – 2018

12.2.3.5.4.2. Market Forecast, 2019 – 2027

12.2.3.5.5. Latin America

12.2.3.5.5.1. Market Estimation, 2013 – 2018

12.2.3.5.5.2. Market Forecast, 2019 – 2027

12.2.4. Microarray Analysis

12.2.4.1. Definition

12.2.4.2. Market Estimation and Penetration, 2013 – 2018

12.2.4.3. Market Forecast, 2019 – 2027

12.2.4.4. Compound Annual Growth Rate (CAGR)

12.2.4.5. Regional Bifurcation

12.2.4.5.1. North America

12.2.4.5.1.1. Market Estimation, 2013 – 2018

12.2.4.5.1.2. Market Forecast, 2019 – 2027

12.2.4.5.2. Europe

12.2.4.5.2.1. Market Estimation, 2013 – 2018

12.2.4.5.2.2. Market Forecast, 2019 – 2027

12.2.4.5.3. Asia Pacific

12.2.4.5.3.1. Market Estimation, 2013 – 2018

12.2.4.5.3.2. Market Forecast, 2019 – 2027

12.2.4.5.4. Middle East and Africa

12.2.4.5.4.1. Market Estimation, 2013 – 2018

12.2.4.5.4.2. Market Forecast, 2019 – 2027

12.2.4.5.5. Latin America

12.2.4.5.5.1. Market Estimation, 2013 – 2018

12.2.4.5.5.2. Market Forecast, 2019 – 2027

12.2.5. Next-Generation Sequencing

12.2.5.1. Definition

12.2.5.2. Market Estimation and Penetration, 2013 – 2018

12.2.5.3. Market Forecast, 2019 – 2027

12.2.5.4. Compound Annual Growth Rate (CAGR)

12.2.5.5. Regional Bifurcation

12.2.5.5.1. North America

12.2.5.5.1.1. Market Estimation, 2013 – 2018

12.2.5.5.1.2. Market Forecast, 2019 – 2027

12.2.5.5.2. Europe

12.2.5.5.2.1. Market Estimation, 2013 – 2018

12.2.5.5.2.2. Market Forecast, 2019 – 2027

12.2.5.5.3. Asia Pacific

12.2.5.5.3.1. Market Estimation, 2013 – 2018

12.2.5.5.3.2. Market Forecast, 2019 – 2027

12.2.5.5.4. Middle East and Africa

12.2.5.5.4.1. Market Estimation, 2013 – 2018

12.2.5.5.4.2. Market Forecast, 2019 – 2027

12.2.5.5.5. Latin America

12.2.5.5.5.1. Market Estimation, 2013 – 2018

12.2.5.5.5.2. Market Forecast, 2019 – 2027

12.2.6. Northern Blot Analysis

12.2.6.1. Definition

12.2.6.2. Market Estimation and Penetration, 2013 – 2018

12.2.6.3. Market Forecast, 2019 – 2027

12.2.6.4. Compound Annual Growth Rate (CAGR)

12.2.6.5. Regional Bifurcation

12.2.6.5.1. North America

12.2.6.5.1.1. Market Estimation, 2013 – 2018

12.2.6.5.1.2. Market Forecast, 2019 – 2027

12.2.6.5.2. Europe

12.2.6.5.2.1. Market Estimation, 2013 – 2018

12.2.6.5.2.2. Market Forecast, 2019 – 2027

12.2.6.5.3. Asia Pacific

12.2.6.5.3.1. Market Estimation, 2013 – 2018

12.2.6.5.3.2. Market Forecast, 2019 – 2027

12.2.6.5.4. Middle East and Africa

12.2.6.5.4.1. Market Estimation, 2013 – 2018

12.2.6.5.4.2. Market Forecast, 2019 – 2027

12.2.6.5.5. Latin America

12.2.6.5.5.1. Market Estimation, 2013 – 2018

12.2.6.5.5.2. Market Forecast, 2019 – 2027

12.2.7. Pathogen Detection

12.2.7.1. Definition

12.2.7.2. Market Estimation and Penetration, 2013 – 2018

12.2.7.3. Market Forecast, 2019 – 2027

12.2.7.4. Compound Annual Growth Rate (CAGR)

12.2.7.5. Regional Bifurcation

12.2.7.5.1. North America

12.2.7.5.1.1. Market Estimation, 2013 – 2018

12.2.7.5.1.2. Market Forecast, 2019 – 2027

12.2.7.5.2. Europe

12.2.7.5.2.1. Market Estimation, 2013 – 2018

12.2.7.5.2.2. Market Forecast, 2019 – 2027

12.2.7.5.3. Asia Pacific

12.2.7.5.3.1. Market Estimation, 2013 – 2018

12.2.7.5.3.2. Market Forecast, 2019 – 2027

12.2.7.5.4. Middle East and Africa

12.2.7.5.4.1. Market Estimation, 2013 – 2018

12.2.7.5.4.2. Market Forecast, 2019 – 2027

12.2.7.5.5. Latin America

12.2.7.5.5.1. Market Estimation, 2013 – 2018

12.2.7.5.5.2. Market Forecast, 2019 – 2027

12.2.8. Others

12.2.8.1. Definition

12.2.8.2. Market Estimation and Penetration, 2013 – 2018

12.2.8.3. Market Forecast, 2019 – 2027

12.2.8.4. Compound Annual Growth Rate (CAGR)

12.2.8.5. Regional Bifurcation

12.2.8.5.1. North America

12.2.8.5.1.1. Market Estimation, 2013 – 2018

12.2.8.5.1.2. Market Forecast, 2019 – 2027

12.2.8.5.2. Europe

12.2.8.5.2.1. Market Estimation, 2013 – 2018

12.2.8.5.2.2. Market Forecast, 2019 – 2027

12.2.8.5.3. Asia Pacific

12.2.8.5.3.1. Market Estimation, 2013 – 2018

12.2.8.5.3.2. Market Forecast, 2019 – 2027

12.2.8.5.4. Middle East and Africa

12.2.8.5.4.1. Market Estimation, 2013 – 2018

12.2.8.5.4.2. Market Forecast, 2019 – 2027

12.2.8.5.5. Latin America

12.2.8.5.5.1. Market Estimation, 2013 – 2018

12.2.8.5.5.2. Market Forecast, 2019 – 2027

12.3. Key Segment for Channeling Investments

12.3.1. By Application

13. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

13.1. Overview

13.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

13.2.1. Hospitals

13.2.1.1. Definition

13.2.1.2. Market Estimation and Penetration, 2013 – 2018

13.2.1.3. Market Forecast, 2019 – 2027

13.2.1.4. Compound Annual Growth Rate (CAGR)

13.2.1.5. Regional Bifurcation

13.2.1.5.1. North America

13.2.1.5.1.1. Market Estimation, 2013 – 2018

13.2.1.5.1.2. Market Forecast, 2019 – 2027

13.2.1.5.2. Europe

13.2.1.5.2.1. Market Estimation, 2013 – 2018

13.2.1.5.2.2. Market Forecast, 2019 – 2027

13.2.1.5.3. Asia Pacific

13.2.1.5.3.1. Market Estimation, 2013 – 2018

13.2.1.5.3.2. Market Forecast, 2019 – 2027

13.2.1.5.4. Middle East and Africa

13.2.1.5.4.1. Market Estimation, 2013 – 2018

13.2.1.5.4.2. Market Forecast, 2019 – 2027

13.2.1.5.5. Latin America

13.2.1.5.5.1. Market Estimation, 2013 – 2018

13.2.1.5.5.2. Market Forecast, 2019 – 2027

13.2.2. Laboratories

13.2.2.1. Definition

13.2.2.2. Market Estimation and Penetration, 2013 – 2018

13.2.2.3. Market Forecast, 2019 – 2027

13.2.2.4. Compound Annual Growth Rate (CAGR)

13.2.2.5. Regional Bifurcation

13.2.2.5.1. North America

13.2.2.5.1.1. Market Estimation, 2013 – 2018

13.2.2.5.1.2. Market Forecast, 2019 – 2027

13.2.2.5.2. Europe

13.2.2.5.2.1. Market Estimation, 2013 – 2018

13.2.2.5.2.2. Market Forecast, 2019 – 2027

13.2.2.5.3. Asia Pacific

13.2.2.5.3.1. Market Estimation, 2013 – 2018

13.2.2.5.3.2. Market Forecast, 2019 – 2027

13.2.2.5.4. Middle East and Africa

13.2.2.5.4.1. Market Estimation, 2013 – 2018

13.2.2.5.4.2. Market Forecast, 2019 – 2027

13.2.2.5.5. Latin America

13.2.2.5.5.1. Market Estimation, 2013 – 2018

13.2.2.5.5.2. Market Forecast, 2019 – 2027

13.2.3. Others

13.2.3.1. Definition

13.2.3.2. Market Estimation and Penetration, 2013 – 2018

13.2.3.3. Market Forecast, 2019 – 2027

13.2.3.4. Compound Annual Growth Rate (CAGR)

13.2.3.5. Regional Bifurcation

13.2.3.5.1. North America

13.2.3.5.1.1. Market Estimation, 2013 – 2018

13.2.3.5.1.2. Market Forecast, 2019 – 2027

13.2.3.5.2. Europe

13.2.3.5.2.1. Market Estimation, 2013 – 2018

13.2.3.5.2.2. Market Forecast, 2019 – 2027

13.2.3.5.3. Asia Pacific

13.2.3.5.3.1. Market Estimation, 2013 – 2018

13.2.3.5.3.2. Market Forecast, 2019 – 2027

13.2.3.5.4. Middle East and Africa

13.2.3.5.4.1. Market Estimation, 2013 – 2018

13.2.3.5.4.2. Market Forecast, 2019 – 2027

13.2.3.5.5. Latin America

13.2.3.5.5.1. Market Estimation, 2013 – 2018

13.2.3.5.5.2. Market Forecast, 2019 – 2027

13.3. Key Segment for Channeling Investments

13.3.1. By End User

14. Global DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 – 2027

14.1. Overview

14.2. Global DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

14.2.1. Direct

14.2.1.1. Definition

14.2.1.2. Market Estimation and Penetration, 2013 – 2018

14.2.1.3. Market Forecast, 2019 – 2027

14.2.1.4. Compound Annual Growth Rate (CAGR)

14.2.1.5. Regional Bifurcation

14.2.1.5.1. North America

14.2.1.5.1.1. Market Estimation, 2013 – 2018

14.2.1.5.1.2. Market Forecast, 2019 – 2027

14.2.1.5.2. Europe

14.2.1.5.2.1. Market Estimation, 2013 – 2018

14.2.1.5.2.2. Market Forecast, 2019 – 2027

14.2.1.5.3. Asia Pacific

14.2.1.5.3.1. Market Estimation, 2013 – 2018

14.2.1.5.3.2. Market Forecast, 2019 – 2027

14.2.1.5.4. Middle East and Africa

14.2.1.5.4.1. Market Estimation, 2013 – 2018

14.2.1.5.4.2. Market Forecast, 2019 – 2027

14.2.1.5.5. Latin America

14.2.1.5.5.1. Market Estimation, 2013 – 2018

14.2.1.5.5.2. Market Forecast, 2019 – 2027

14.2.2. Indirect

14.2.2.1. Definition

14.2.2.2. Market Estimation and Penetration, 2013 – 2018

14.2.2.3. Market Forecast, 2019 – 2027

14.2.2.4. Compound Annual Growth Rate (CAGR)

14.2.2.5. Regional Bifurcation

14.2.2.5.1. North America

14.2.2.5.1.1. Market Estimation, 2013 – 2018

14.2.2.5.1.2. Market Forecast, 2019 – 2027

14.2.2.5.2. Europe

14.2.2.5.2.1. Market Estimation, 2013 – 2018

14.2.2.5.2.2. Market Forecast, 2019 – 2027

14.2.2.5.3. Asia Pacific

14.2.2.5.3.1. Market Estimation, 2013 – 2018

14.2.2.5.3.2. Market Forecast, 2019 – 2027

14.2.2.5.4. Middle East and Africa

14.2.2.5.4.1. Market Estimation, 2013 – 2018

14.2.2.5.4.2. Market Forecast, 2019 – 2027

14.2.2.5.5. Latin America

14.2.2.5.5.1. Market Estimation, 2013 – 2018

14.2.2.5.5.2. Market Forecast, 2019 – 2027

14.3. Key Segment for Channeling Investments

14.3.1. By Sales Channel

15. North America DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn)

15.2. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

15.2.1. Total RNA

15.2.2. Cell-free DNA

15.2.3. Viral DNA/RNA

15.2.4. Purified RNA

15.2.5. Sequence-Specific DNA/RNA

15.2.6. Others

15.3. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

15.3.1. Automated

15.3.2. Manual

15.4. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

15.4.1. Miniprep

15.4.2. Midiprep

15.4.3. Maxiprep

15.4.4. Others

15.5. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.5.1. Blood

15.5.2. Nasal Swabs

15.5.3. Tissues

15.5.4. Saliva

15.5.5. Serum and Plasma

15.5.6. Stool

15.5.7. Cerebral Fluid

15.5.8. Others

15.6. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

15.6.1. cDNA Synthesis

15.6.2. Cloning

15.6.3. Real Time PCR

15.6.4. Microarray Analysis

15.6.5. Next-Generation Sequencing

15.6.6. Northern Blot Analysis

15.6.7. Pathogen Detection

15.6.8. Others

15.7. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

15.7.1. Hospitals

15.7.2. Laboratories

15.7.3. Others

15.8. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

15.8.1. Direct

15.8.2. Indirect

15.9. North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

15.9.1. U.S

15.9.1.1. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

15.9.1.1.1. Total RNA

15.9.1.1.2. Cell-free DNA

15.9.1.1.3. Viral DNA/RNA

15.9.1.1.4. Purified RNA

15.9.1.1.5. Sequence-Specific DNA/RNA

15.9.1.1.6. Others

15.9.1.2. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

15.9.1.2.1. Automated

15.9.1.2.2. Manual

15.9.1.3. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

15.9.1.3.1. Miniprep

15.9.1.3.2. Midiprep

15.9.1.3.3. Maxiprep

15.9.1.3.4. Others

15.9.1.4. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.9.1.4.1. Blood

15.9.1.4.2. Nasal Swabs

15.9.1.4.3. Tissues

15.9.1.4.4. Saliva

15.9.1.4.5. Serum and Plasma

15.9.1.4.6. Stool

15.9.1.4.7. Cerebral Fluid

15.9.1.4.8. Others

15.9.1.5. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

15.9.1.5.1. cDNA Synthesis

15.9.1.5.2. Cloning

15.9.1.5.3. Real Time PCR

15.9.1.5.4. Microarray Analysis

15.9.1.5.5. Next-Generation Sequencing

15.9.1.5.6. Northern Blot Analysis

15.9.1.5.7. Pathogen Detection

15.9.1.5.8. Others

15.9.1.6. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

15.9.1.6.1. Hospitals

15.9.1.6.2. Laboratories

15.9.1.6.3. Others

15.9.1.7. U.S DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

15.9.1.7.1. Direct

15.9.1.7.2. Indirect

15.9.2. Canada

15.9.2.1. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

15.9.2.1.1. Total RNA

15.9.2.1.2. Cell-free DNA

15.9.2.1.3. Viral DNA/RNA

15.9.2.1.4. Purified RNA

15.9.2.1.5. Sequence-Specific DNA/RNA

15.9.2.1.6. Others

15.9.2.2. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

15.9.2.2.1. Automated

15.9.2.2.2. Manual

15.9.2.3. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

15.9.2.3.1. Miniprep

15.9.2.3.2. Midiprep

15.9.2.3.3. Maxiprep

15.9.2.3.4. Others

15.9.2.4. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.9.2.4.1. Blood

15.9.2.4.2. Nasal Swabs

15.9.2.4.3. Tissues

15.9.2.4.4. Saliva

15.9.2.4.5. Serum and Plasma

15.9.2.4.6. Stool

15.9.2.4.7. Cerebral Fluid

15.9.2.4.8. Others

15.9.2.5. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

15.9.2.5.1. cDNA Synthesis

15.9.2.5.2. Cloning

15.9.2.5.3. Real Time PCR

15.9.2.5.4. Microarray Analysis

15.9.2.5.5. Next-Generation Sequencing

15.9.2.5.6. Northern Blot Analysis

15.9.2.5.7. Pathogen Detection

15.9.2.5.8. Others

15.9.2.6. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

15.9.2.6.1. Hospitals

15.9.2.6.2. Laboratories

15.9.2.6.3. Others

15.9.2.7. Canada DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

15.9.2.7.1. Direct

15.9.2.7.2. Indirect

15.9.3. Mexico

15.9.3.1. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

15.9.3.1.1. Total RNA

15.9.3.1.2. Cell-free DNA

15.9.3.1.3. Viral DNA/RNA

15.9.3.1.4. Purified RNA

15.9.3.1.5. Sequence-Specific DNA/RNA

15.9.3.1.6. Others

15.9.3.2. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

15.9.3.2.1. Automated

15.9.3.2.2. Manual

15.9.3.3. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

15.9.3.3.1. Miniprep

15.9.3.3.2. Midiprep

15.9.3.3.3. Maxiprep

15.9.3.3.4. Others

15.9.3.4. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.9.3.4.1. Blood

15.9.3.4.2. Nasal Swabs

15.9.3.4.3. Tissues

15.9.3.4.4. Saliva

15.9.3.4.5. Serum and Plasma

15.9.3.4.6. Stool

15.9.3.4.7. Cerebral Fluid

15.9.3.4.8. Others

15.9.3.5. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

15.9.3.5.1. cDNA Synthesis

15.9.3.5.2. Cloning

15.9.3.5.3. Real Time PCR

15.9.3.5.4. Microarray Analysis

15.9.3.5.5. Next-Generation Sequencing

15.9.3.5.6. Northern Blot Analysis

15.9.3.5.7. Pathogen Detection

15.9.3.5.8. Others

15.9.3.6. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

15.9.3.6.1. Hospitals

15.9.3.6.2. Laboratories

15.9.3.6.3. Others

15.9.3.7. Mexico DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

15.9.3.7.1. Direct

15.9.3.7.2. Indirect

15.9.4. Rest of North America

15.9.4.1. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

15.9.4.1.1. Total RNA

15.9.4.1.2. Cell-free DNA

15.9.4.1.3. Viral DNA/RNA

15.9.4.1.4. Purified RNA

15.9.4.1.5. Sequence-Specific DNA/RNA

15.9.4.1.6. Others

15.9.4.2. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

15.9.4.2.1. Automated

15.9.4.2.2. Manual

15.9.4.3. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

15.9.4.3.1. Miniprep

15.9.4.3.2. Midiprep

15.9.4.3.3. Maxiprep

15.9.4.3.4. Others

15.9.4.4. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.9.4.4.1. Blood

15.9.4.4.2. Nasal Swabs

15.9.4.4.3. Tissues

15.9.4.4.4. Saliva

15.9.4.4.5. Serum and Plasma

15.9.4.4.6. Stool

15.9.4.4.7. Cerebral Fluid

15.9.4.4.8. Others

15.9.4.5. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

15.9.4.5.1. cDNA Synthesis

15.9.4.5.2. Cloning

15.9.4.5.3. Real Time PCR

15.9.4.5.4. Microarray Analysis

15.9.4.5.5. Next-Generation Sequencing

15.9.4.5.6. Northern Blot Analysis

15.9.4.5.7. Pathogen Detection

15.9.4.5.8. Others

15.9.4.6. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

15.9.4.6.1. Hospitals

15.9.4.6.2. Laboratories

15.9.4.6.3. Others

15.9.4.7. Rest of North America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

15.9.4.7.1. Direct

15.9.4.7.2. Indirect

15.10. Key Segment for Channeling Investments

15.10.1. By Country

15.10.2. By Type

15.10.3. By Format

15.10.4. By Kit Size

15.10.5. By Sample Type

15.10.6. By Application

15.10.7. By End User

15.10.8. By Sales Channel

16. Europe DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 - 2027

16.1. Overview

16.1.1. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn)

16.2. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.2.1. Total RNA

16.2.2. Cell-free DNA

16.2.3. Viral DNA/RNA

16.2.4. Purified RNA

16.2.5. Sequence-Specific DNA/RNA

16.2.6. Others

16.3. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.3.1. Automated

16.3.2. Manual

16.4. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.4.1. Miniprep

16.4.2. Midiprep

16.4.3. Maxiprep

16.4.4. Others

16.5. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.5.1. Blood

16.5.2. Nasal Swabs

16.5.3. Tissues

16.5.4. Saliva

16.5.5. Serum and Plasma

16.5.6. Stool

16.5.7. Cerebral Fluid

16.5.8. Others

16.6. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.6.1. cDNA Synthesis

16.6.2. Cloning

16.6.3. Real Time PCR

16.6.4. Microarray Analysis

16.6.5. Next-Generation Sequencing

16.6.6. Northern Blot Analysis

16.6.7. Pathogen Detection

16.6.8. Others

16.7. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.7.1. Hospitals

16.7.2. Laboratories

16.7.3. Others

16.8. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.8.1. Direct

16.8.2. Indirect

16.9. Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

16.9.1. France

16.9.1.1. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.1.1.1. Total RNA

16.9.1.1.2. Cell-free DNA

16.9.1.1.3. Viral DNA/RNA

16.9.1.1.4. Purified RNA

16.9.1.1.5. Sequence-Specific DNA/RNA

16.9.1.1.6. Others

16.9.1.2. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.1.2.1. Automated

16.9.1.2.2. Manual

16.9.1.3. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.1.3.1. Miniprep

16.9.1.3.2. Midiprep

16.9.1.3.3. Maxiprep

16.9.1.3.4. Others

16.9.1.4. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.1.4.1. Blood

16.9.1.4.2. Nasal Swabs

16.9.1.4.3. Tissues

16.9.1.4.4. Saliva

16.9.1.4.5. Serum and Plasma

16.9.1.4.6. Stool

16.9.1.4.7. Cerebral Fluid

16.9.1.4.8. Others

16.9.1.5. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.1.5.1. cDNA Synthesis

16.9.1.5.2. Cloning

16.9.1.5.3. Real Time PCR

16.9.1.5.4. Microarray Analysis

16.9.1.5.5. Next-Generation Sequencing

16.9.1.5.6. Northern Blot Analysis

16.9.1.5.7. Pathogen Detection

16.9.1.5.8. Others

16.9.1.6. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.1.6.1. Hospitals

16.9.1.6.2. Laboratories

16.9.1.6.3. Others

16.9.1.7. France DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.1.7.1. Direct

16.9.1.7.2. Indirect

16.9.2. The UK

16.9.2.1. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.2.1.1. Total RNA

16.9.2.1.2. Cell-free DNA

16.9.2.1.3. Viral DNA/RNA

16.9.2.1.4. Purified RNA

16.9.2.1.5. Sequence-Specific DNA/RNA

16.9.2.1.6. Others

16.9.2.2. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.2.2.1. Automated

16.9.2.2.2. Manual

16.9.2.3. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.2.3.1. Miniprep

16.9.2.3.2. Midiprep

16.9.2.3.3. Maxiprep

16.9.2.3.4. Others

16.9.2.4. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.2.4.1. Blood

16.9.2.4.2. Nasal Swabs

16.9.2.4.3. Tissues

16.9.2.4.4. Saliva

16.9.2.4.5. Serum and Plasma

16.9.2.4.6. Stool

16.9.2.4.7. Cerebral Fluid

16.9.2.4.8. Others

16.9.2.5. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.2.5.1. cDNA Synthesis

16.9.2.5.2. Cloning

16.9.2.5.3. Real Time PCR

16.9.2.5.4. Microarray Analysis

16.9.2.5.5. Next-Generation Sequencing

16.9.2.5.6. Northern Blot Analysis

16.9.2.5.7. Pathogen Detection

16.9.2.5.8. Others

16.9.2.6. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.2.6.1. Hospitals

16.9.2.6.2. Laboratories

16.9.2.6.3. Others

16.9.2.7. The UK DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.2.7.1. Direct

16.9.2.7.2. Indirect

16.9.3. Spain

16.9.3.1. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.3.1.1. Total RNA

16.9.3.1.2. Cell-free DNA

16.9.3.1.3. Viral DNA/RNA

16.9.3.1.4. Purified RNA

16.9.3.1.5. Sequence-Specific DNA/RNA

16.9.3.1.6. Others

16.9.3.2. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.3.2.1. Automated

16.9.3.2.2. Manual

16.9.3.3. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.3.3.1. Miniprep

16.9.3.3.2. Midiprep

16.9.3.3.3. Maxiprep

16.9.3.3.4. Others

16.9.3.4. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.3.4.1. Blood

16.9.3.4.2. Nasal Swabs

16.9.3.4.3. Tissues

16.9.3.4.4. Saliva

16.9.3.4.5. Serum and Plasma

16.9.3.4.6. Stool

16.9.3.4.7. Cerebral Fluid

16.9.3.4.8. Others

16.9.3.5. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.3.5.1. cDNA Synthesis

16.9.3.5.2. Cloning

16.9.3.5.3. Real Time PCR

16.9.3.5.4. Microarray Analysis

16.9.3.5.5. Next-Generation Sequencing

16.9.3.5.6. Northern Blot Analysis

16.9.3.5.7. Pathogen Detection

16.9.3.5.8. Others

16.9.3.6. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.3.6.1. Hospitals

16.9.3.6.2. Laboratories

16.9.3.6.3. Others

16.9.3.7. Spain DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.3.7.1. Direct

16.9.3.7.2. Indirect

16.9.4. Germany

16.9.4.1. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.4.1.1. Total RNA

16.9.4.1.2. Cell-free DNA

16.9.4.1.3. Viral DNA/RNA

16.9.4.1.4. Purified RNA

16.9.4.1.5. Sequence-Specific DNA/RNA

16.9.4.1.6. Others

16.9.4.2. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.4.2.1. Automated

16.9.4.2.2. Manual

16.9.4.3. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.4.3.1. Miniprep

16.9.4.3.2. Midiprep

16.9.4.3.3. Maxiprep

16.9.4.3.4. Others

16.9.4.4. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.4.4.1. Blood

16.9.4.4.2. Nasal Swabs

16.9.4.4.3. Tissues

16.9.4.4.4. Saliva

16.9.4.4.5. Serum and Plasma

16.9.4.4.6. Stool

16.9.4.4.7. Cerebral Fluid

16.9.4.4.8. Others

16.9.4.5. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.4.5.1. cDNA Synthesis

16.9.4.5.2. Cloning

16.9.4.5.3. Real Time PCR

16.9.4.5.4. Microarray Analysis

16.9.4.5.5. Next-Generation Sequencing

16.9.4.5.6. Northern Blot Analysis

16.9.4.5.7. Pathogen Detection

16.9.4.5.8. Others

16.9.4.6. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.4.6.1. Hospitals

16.9.4.6.2. Laboratories

16.9.4.6.3. Others

16.9.4.7. Germany DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.4.7.1. Direct

16.9.4.7.2. Indirect

16.9.5. Italy

16.9.5.1. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.5.1.1. Total RNA

16.9.5.1.2. Cell-free DNA

16.9.5.1.3. Viral DNA/RNA

16.9.5.1.4. Purified RNA

16.9.5.1.5. Sequence-Specific DNA/RNA

16.9.5.1.6. Others

16.9.5.2. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.5.2.1. Automated

16.9.5.2.2. Manual

16.9.5.3. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.5.3.1. Miniprep

16.9.5.3.2. Midiprep

16.9.5.3.3. Maxiprep

16.9.5.3.4. Others

16.9.5.4. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.5.4.1. Blood

16.9.5.4.2. Nasal Swabs

16.9.5.4.3. Tissues

16.9.5.4.4. Saliva

16.9.5.4.5. Serum and Plasma

16.9.5.4.6. Stool

16.9.5.4.7. Cerebral Fluid

16.9.5.4.8. Others

16.9.5.5. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.5.5.1. cDNA Synthesis

16.9.5.5.2. Cloning

16.9.5.5.3. Real Time PCR

16.9.5.5.4. Microarray Analysis

16.9.5.5.5. Next-Generation Sequencing

16.9.5.5.6. Northern Blot Analysis

16.9.5.5.7. Pathogen Detection

16.9.5.5.8. Others

16.9.5.6. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.5.6.1. Hospitals

16.9.5.6.2. Laboratories

16.9.5.6.3. Others

16.9.5.7. Italy DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.5.7.1. Direct

16.9.5.7.2. Indirect

16.9.6. Nordic Countries

16.9.6.1. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.6.1.1. Total RNA

16.9.6.1.2. Cell-free DNA

16.9.6.1.3. Viral DNA/RNA

16.9.6.1.4. Purified RNA

16.9.6.1.5. Sequence-Specific DNA/RNA

16.9.6.1.6. Others

16.9.6.2. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.6.2.1. Automated

16.9.6.2.2. Manual

16.9.6.3. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.6.3.1. Miniprep

16.9.6.3.2. Midiprep

16.9.6.3.3. Maxiprep

16.9.6.3.4. Others

16.9.6.4. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.6.4.1. Blood

16.9.6.4.2. Nasal Swabs

16.9.6.4.3. Tissues

16.9.6.4.4. Saliva

16.9.6.4.5. Serum and Plasma

16.9.6.4.6. Stool

16.9.6.4.7. Cerebral Fluid

16.9.6.4.8. Others

16.9.6.5. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.6.5.1. cDNA Synthesis

16.9.6.5.2. Cloning

16.9.6.5.3. Real Time PCR

16.9.6.5.4. Microarray Analysis

16.9.6.5.5. Next-Generation Sequencing

16.9.6.5.6. Northern Blot Analysis

16.9.6.5.7. Pathogen Detection

16.9.6.5.8. Others

16.9.6.6. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.6.6.1. Hospitals

16.9.6.6.2. Laboratories

16.9.6.6.3. Others

16.9.6.7. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.6.7.1. Direct

16.9.6.7.2. Indirect

16.9.6.8. Nordic Countries DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

16.9.6.8.1. Denmark

16.9.6.8.2. Finland

16.9.6.8.3. Iceland

16.9.6.8.4. Sweden

16.9.6.8.5. Norway

16.9.7. Benelux Union

16.9.7.1. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.7.1.1. Total RNA

16.9.7.1.2. Cell-free DNA

16.9.7.1.3. Viral DNA/RNA

16.9.7.1.4. Purified RNA

16.9.7.1.5. Sequence-Specific DNA/RNA

16.9.7.1.6. Others

16.9.7.2. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.7.2.1. Automated

16.9.7.2.2. Manual

16.9.7.3. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.7.3.1. Miniprep

16.9.7.3.2. Midiprep

16.9.7.3.3. Maxiprep

16.9.7.3.4. Others

16.9.7.4. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.7.4.1. Blood

16.9.7.4.2. Nasal Swabs

16.9.7.4.3. Tissues

16.9.7.4.4. Saliva

16.9.7.4.5. Serum and Plasma

16.9.7.4.6. Stool

16.9.7.4.7. Cerebral Fluid

16.9.7.4.8. Others

16.9.7.5. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.7.5.1. cDNA Synthesis

16.9.7.5.2. Cloning

16.9.7.5.3. Real Time PCR

16.9.7.5.4. Microarray Analysis

16.9.7.5.5. Next-Generation Sequencing

16.9.7.5.6. Northern Blot Analysis

16.9.7.5.7. Pathogen Detection

16.9.7.5.8. Others

16.9.7.6. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.7.6.1. Hospitals

16.9.7.6.2. Laboratories

16.9.7.6.3. Others

16.9.7.7. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.7.7.1. Direct

16.9.7.7.2. Indirect

16.9.7.8. Benelux Union DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

16.9.7.8.1. Belgium

16.9.7.8.2. The Netherlands

16.9.7.8.3. Luxembourg

16.9.8. Rest of Europe

16.9.8.1. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

16.9.8.1.1. Total RNA

16.9.8.1.2. Cell-free DNA

16.9.8.1.3. Viral DNA/RNA

16.9.8.1.4. Purified RNA

16.9.8.1.5. Sequence-Specific DNA/RNA

16.9.8.1.6. Others

16.9.8.2. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

16.9.8.2.1. Automated

16.9.8.2.2. Manual

16.9.8.3. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

16.9.8.3.1. Miniprep

16.9.8.3.2. Midiprep

16.9.8.3.3. Maxiprep

16.9.8.3.4. Others

16.9.8.4. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.9.8.4.1. Blood

16.9.8.4.2. Nasal Swabs

16.9.8.4.3. Tissues

16.9.8.4.4. Saliva

16.9.8.4.5. Serum and Plasma

16.9.8.4.6. Stool

16.9.8.4.7. Cerebral Fluid

16.9.8.4.8. Others

16.9.8.5. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

16.9.8.5.1. cDNA Synthesis

16.9.8.5.2. Cloning

16.9.8.5.3. Real Time PCR

16.9.8.5.4. Microarray Analysis

16.9.8.5.5. Next-Generation Sequencing

16.9.8.5.6. Northern Blot Analysis

16.9.8.5.7. Pathogen Detection

16.9.8.5.8. Others

16.9.8.6. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

16.9.8.6.1. Hospitals

16.9.8.6.2. Laboratories

16.9.8.6.3. Others

16.9.8.7. Rest of Europe DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

16.9.8.7.1. Direct

16.9.8.7.2. Indirect

16.10. Key Segment for Channeling Investments

16.10.1. By Country

16.10.2. By Type

16.10.3. By Format

16.10.4. By Kit Size

16.10.5. By Sample Type

16.10.6. By Application

16.10.7. By End User

16.10.8. By Sales Channel

17. Asia Pacific DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 - 2027

17.1. Overview

17.1.1. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn)

17.2. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.2.1. Total RNA

17.2.2. Cell-free DNA

17.2.3. Viral DNA/RNA

17.2.4. Purified RNA

17.2.5. Sequence-Specific DNA/RNA

17.2.6. Others

17.3. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.3.1. Automated

17.3.2. Manual

17.4. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.4.1. Miniprep

17.4.2. Midiprep

17.4.3. Maxiprep

17.4.4. Others

17.5. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.5.1. Blood

17.5.2. Nasal Swabs

17.5.3. Tissues

17.5.4. Saliva

17.5.5. Serum and Plasma

17.5.6. Stool

17.5.7. Cerebral Fluid

17.5.8. Others

17.6. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.6.1. cDNA Synthesis

17.6.2. Cloning

17.6.3. Real Time PCR

17.6.4. Microarray Analysis

17.6.5. Next-Generation Sequencing

17.6.6. Northern Blot Analysis

17.6.7. Pathogen Detection

17.6.8. Others

17.7. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.7.1. Hospitals

17.7.2. Laboratories

17.7.3. Others

17.8. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.8.1. Direct

17.8.2. Indirect

17.9. Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

17.9.1. China

17.9.1.1. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.1.1.1. Total RNA

17.9.1.1.2. Cell-free DNA

17.9.1.1.3. Viral DNA/RNA

17.9.1.1.4. Purified RNA

17.9.1.1.5. Sequence-Specific DNA/RNA

17.9.1.1.6. Others

17.9.1.2. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.1.2.1. Automated

17.9.1.2.2. Manual

17.9.1.3. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.1.3.1. Miniprep

17.9.1.3.2. Midiprep

17.9.1.3.3. Maxiprep

17.9.1.3.4. Others

17.9.1.4. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.1.4.1. Blood

17.9.1.4.2. Nasal Swabs

17.9.1.4.3. Tissues

17.9.1.4.4. Saliva

17.9.1.4.5. Serum and Plasma

17.9.1.4.6. Stool

17.9.1.4.7. Cerebral Fluid

17.9.1.4.8. Others

17.9.1.5. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.1.5.1. cDNA Synthesis

17.9.1.5.2. Cloning

17.9.1.5.3. Real Time PCR

17.9.1.5.4. Microarray Analysis

17.9.1.5.5. Next-Generation Sequencing

17.9.1.5.6. Northern Blot Analysis

17.9.1.5.7. Pathogen Detection

17.9.1.5.8. Others

17.9.1.6. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.1.6.1. Hospitals

17.9.1.6.2. Laboratories

17.9.1.6.3. Others

17.9.1.7. China DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.1.7.1. Direct

17.9.1.7.2. Indirect

17.9.2. Japan

17.9.2.1. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.2.1.1. Total RNA

17.9.2.1.2. Cell-free DNA

17.9.2.1.3. Viral DNA/RNA

17.9.2.1.4. Purified RNA

17.9.2.1.5. Sequence-Specific DNA/RNA

17.9.2.1.6. Others

17.9.2.2. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.2.2.1. Automated

17.9.2.2.2. Manual

17.9.2.3. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.2.3.1. Miniprep

17.9.2.3.2. Midiprep

17.9.2.3.3. Maxiprep

17.9.2.3.4. Others

17.9.2.4. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.2.4.1. Blood

17.9.2.4.2. Nasal Swabs

17.9.2.4.3. Tissues

17.9.2.4.4. Saliva

17.9.2.4.5. Serum and Plasma

17.9.2.4.6. Stool

17.9.2.4.7. Cerebral Fluid

17.9.2.4.8. Others

17.9.2.5. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.2.5.1. cDNA Synthesis

17.9.2.5.2. Cloning

17.9.2.5.3. Real Time PCR

17.9.2.5.4. Microarray Analysis

17.9.2.5.5. Next-Generation Sequencing

17.9.2.5.6. Northern Blot Analysis

17.9.2.5.7. Pathogen Detection

17.9.2.5.8. Others

17.9.2.6. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.2.6.1. Hospitals

17.9.2.6.2. Laboratories

17.9.2.6.3. Others

17.9.2.7. Japan DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.2.7.1. Direct

17.9.2.7.2. Indirect

17.9.3. India

17.9.3.1. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.3.1.1. Total RNA

17.9.3.1.2. Cell-free DNA

17.9.3.1.3. Viral DNA/RNA

17.9.3.1.4. Purified RNA

17.9.3.1.5. Sequence-Specific DNA/RNA

17.9.3.1.6. Others

17.9.3.2. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.3.2.1. Automated

17.9.3.2.2. Manual

17.9.3.3. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.3.3.1. Miniprep

17.9.3.3.2. Midiprep

17.9.3.3.3. Maxiprep

17.9.3.3.4. Others

17.9.3.4. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.3.4.1. Blood

17.9.3.4.2. Nasal Swabs

17.9.3.4.3. Tissues

17.9.3.4.4. Saliva

17.9.3.4.5. Serum and Plasma

17.9.3.4.6. Stool

17.9.3.4.7. Cerebral Fluid

17.9.3.4.8. Others

17.9.3.5. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.3.5.1. cDNA Synthesis

17.9.3.5.2. Cloning

17.9.3.5.3. Real Time PCR

17.9.3.5.4. Microarray Analysis

17.9.3.5.5. Next-Generation Sequencing

17.9.3.5.6. Northern Blot Analysis

17.9.3.5.7. Pathogen Detection

17.9.3.5.8. Others

17.9.3.6. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.3.6.1. Hospitals

17.9.3.6.2. Laboratories

17.9.3.6.3. Others

17.9.3.7. India DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.3.7.1. Direct

17.9.3.7.2. Indirect

17.9.4. New Zealand

17.9.4.1. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.4.1.1. Total RNA

17.9.4.1.2. Cell-free DNA

17.9.4.1.3. Viral DNA/RNA

17.9.4.1.4. Purified RNA

17.9.4.1.5. Sequence-Specific DNA/RNA

17.9.4.1.6. Others

17.9.4.2. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.4.2.1. Automated

17.9.4.2.2. Manual

17.9.4.3. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.4.3.1. Miniprep

17.9.4.3.2. Midiprep

17.9.4.3.3. Maxiprep

17.9.4.3.4. Others

17.9.4.4. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.4.4.1. Blood

17.9.4.4.2. Nasal Swabs

17.9.4.4.3. Tissues

17.9.4.4.4. Saliva

17.9.4.4.5. Serum and Plasma

17.9.4.4.6. Stool

17.9.4.4.7. Cerebral Fluid

17.9.4.4.8. Others

17.9.4.5. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.4.5.1. cDNA Synthesis

17.9.4.5.2. Cloning

17.9.4.5.3. Real Time PCR

17.9.4.5.4. Microarray Analysis

17.9.4.5.5. Next-Generation Sequencing

17.9.4.5.6. Northern Blot Analysis

17.9.4.5.7. Pathogen Detection

17.9.4.5.8. Others

17.9.4.6. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.4.6.1. Hospitals

17.9.4.6.2. Laboratories

17.9.4.6.3. Others

17.9.4.7. New Zealand DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.4.7.1. Direct

17.9.4.7.2. Indirect

17.9.5. Australia

17.9.5.1. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.5.1.1. Total RNA

17.9.5.1.2. Cell-free DNA

17.9.5.1.3. Viral DNA/RNA

17.9.5.1.4. Purified RNA

17.9.5.1.5. Sequence-Specific DNA/RNA

17.9.5.1.6. Others

17.9.5.2. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.5.2.1. Automated

17.9.5.2.2. Manual

17.9.5.3. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.5.3.1. Miniprep

17.9.5.3.2. Midiprep

17.9.5.3.3. Maxiprep

17.9.5.3.4. Others

17.9.5.4. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.5.4.1. Blood

17.9.5.4.2. Nasal Swabs

17.9.5.4.3. Tissues

17.9.5.4.4. Saliva

17.9.5.4.5. Serum and Plasma

17.9.5.4.6. Stool

17.9.5.4.7. Cerebral Fluid

17.9.5.4.8. Others

17.9.5.5. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.5.5.1. cDNA Synthesis

17.9.5.5.2. Cloning

17.9.5.5.3. Real Time PCR

17.9.5.5.4. Microarray Analysis

17.9.5.5.5. Next-Generation Sequencing

17.9.5.5.6. Northern Blot Analysis

17.9.5.5.7. Pathogen Detection

17.9.5.5.8. Others

17.9.5.6. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.5.6.1. Hospitals

17.9.5.6.2. Laboratories

17.9.5.6.3. Others

17.9.5.7. Australia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.5.7.1. Direct

17.9.5.7.2. Indirect

17.9.6. South Korea

17.9.6.1. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.6.1.1. Total RNA

17.9.6.1.2. Cell-free DNA

17.9.6.1.3. Viral DNA/RNA

17.9.6.1.4. Purified RNA

17.9.6.1.5. Sequence-Specific DNA/RNA

17.9.6.1.6. Others

17.9.6.2. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.6.2.1. Automated

17.9.6.2.2. Manual

17.9.6.3. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.6.3.1. Miniprep

17.9.6.3.2. Midiprep

17.9.6.3.3. Maxiprep

17.9.6.3.4. Others

17.9.6.4. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.6.4.1. Blood

17.9.6.4.2. Nasal Swabs

17.9.6.4.3. Tissues

17.9.6.4.4. Saliva

17.9.6.4.5. Serum and Plasma

17.9.6.4.6. Stool

17.9.6.4.7. Cerebral Fluid

17.9.6.4.8. Others

17.9.6.5. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.6.5.1. cDNA Synthesis

17.9.6.5.2. Cloning

17.9.6.5.3. Real Time PCR

17.9.6.5.4. Microarray Analysis

17.9.6.5.5. Next-Generation Sequencing

17.9.6.5.6. Northern Blot Analysis

17.9.6.5.7. Pathogen Detection

17.9.6.5.8. Others

17.9.6.6. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.6.6.1. Hospitals

17.9.6.6.2. Laboratories

17.9.6.6.3. Others

17.9.6.7. South Korea DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.6.7.1. Direct

17.9.6.7.2. Indirect

17.9.7. Southeast Asia

17.9.7.1. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.7.1.1. Total RNA

17.9.7.1.2. Cell-free DNA

17.9.7.1.3. Viral DNA/RNA

17.9.7.1.4. Purified RNA

17.9.7.1.5. Sequence-Specific DNA/RNA

17.9.7.1.6. Others

17.9.7.2. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.7.2.1. Automated

17.9.7.2.2. Manual

17.9.7.3. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.7.3.1. Miniprep

17.9.7.3.2. Midiprep

17.9.7.3.3. Maxiprep

17.9.7.3.4. Others

17.9.7.4. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.7.4.1. Blood

17.9.7.4.2. Nasal Swabs

17.9.7.4.3. Tissues

17.9.7.4.4. Saliva

17.9.7.4.5. Serum and Plasma

17.9.7.4.6. Stool

17.9.7.4.7. Cerebral Fluid

17.9.7.4.8. Others

17.9.7.5. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.7.5.1. cDNA Synthesis

17.9.7.5.2. Cloning

17.9.7.5.3. Real Time PCR

17.9.7.5.4. Microarray Analysis

17.9.7.5.5. Next-Generation Sequencing

17.9.7.5.6. Northern Blot Analysis

17.9.7.5.7. Pathogen Detection

17.9.7.5.8. Others

17.9.7.6. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.7.6.1. Hospitals

17.9.7.6.2. Laboratories

17.9.7.6.3. Others

17.9.7.7. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.7.7.1. Direct

17.9.7.7.2. Indirect

17.9.7.8. Southeast Asia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

17.9.7.8.1. Indonesia

17.9.7.8.2. Thailand

17.9.7.8.3. Malaysia

17.9.7.8.4. Singapore

17.9.7.8.5. Rest of Southeast Asia

17.9.8. Rest of Asia Pacific

17.9.8.1. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

17.9.8.1.1. Total RNA

17.9.8.1.2. Cell-free DNA

17.9.8.1.3. Viral DNA/RNA

17.9.8.1.4. Purified RNA

17.9.8.1.5. Sequence-Specific DNA/RNA

17.9.8.1.6. Others

17.9.8.2. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

17.9.8.2.1. Automated

17.9.8.2.2. Manual

17.9.8.3. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

17.9.8.3.1. Miniprep

17.9.8.3.2. Midiprep

17.9.8.3.3. Maxiprep

17.9.8.3.4. Others

17.9.8.4. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

17.9.8.4.1. Blood

17.9.8.4.2. Nasal Swabs

17.9.8.4.3. Tissues

17.9.8.4.4. Saliva

17.9.8.4.5. Serum and Plasma

17.9.8.4.6. Stool

17.9.8.4.7. Cerebral Fluid

17.9.8.4.8. Others

17.9.8.5. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

17.9.8.5.1. cDNA Synthesis

17.9.8.5.2. Cloning

17.9.8.5.3. Real Time PCR

17.9.8.5.4. Microarray Analysis

17.9.8.5.5. Next-Generation Sequencing

17.9.8.5.6. Northern Blot Analysis

17.9.8.5.7. Pathogen Detection

17.9.8.5.8. Others

17.9.8.6. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

17.9.8.6.1. Hospitals

17.9.8.6.2. Laboratories

17.9.8.6.3. Others

17.9.8.7. Rest of Asia Pacific DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

17.9.8.7.1. Direct

17.9.8.7.2. Indirect

17.10. Key Segment for Channeling Investments

17.10.1. By Country

17.10.2. By Type

17.10.3. By Format

17.10.4. By Kit Size

17.10.5. By Sample Type

17.10.6. By Application

17.10.7. By End User

17.10.8. By Sales Channel

18. Middle East and Africa DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 - 2027

18.1. Overview

18.1.1. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn)

18.2. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.2.1. Total RNA

18.2.2. Cell-free DNA

18.2.3. Viral DNA/RNA

18.2.4. Purified RNA

18.2.5. Sequence-Specific DNA/RNA

18.2.6. Others

18.3. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.3.1. Automated

18.3.2. Manual

18.4. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.4.1. Miniprep

18.4.2. Midiprep

18.4.3. Maxiprep

18.4.4. Others

18.5. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.5.1. Blood

18.5.2. Nasal Swabs

18.5.3. Tissues

18.5.4. Saliva

18.5.5. Serum and Plasma

18.5.6. Stool

18.5.7. Cerebral Fluid

18.5.8. Others

18.6. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.6.1. cDNA Synthesis

18.6.2. Cloning

18.6.3. Real Time PCR

18.6.4. Microarray Analysis

18.6.5. Next-Generation Sequencing

18.6.6. Northern Blot Analysis

18.6.7. Pathogen Detection

18.6.8. Others

18.7. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.7.1. Hospitals

18.7.2. Laboratories

18.7.3. Others

18.8. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.8.1. Direct

18.8.2. Indirect

18.9. Middle East and Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

18.9.1. Saudi Arabia

18.9.1.1. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.1.1.1. Total RNA

18.9.1.1.2. Cell-free DNA

18.9.1.1.3. Viral DNA/RNA

18.9.1.1.4. Purified RNA

18.9.1.1.5. Sequence-Specific DNA/RNA

18.9.1.1.6. Others

18.9.1.2. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.1.2.1. Automated

18.9.1.2.2. Manual

18.9.1.3. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.1.3.1. Miniprep

18.9.1.3.2. Midiprep

18.9.1.3.3. Maxiprep

18.9.1.3.4. Others

18.9.1.4. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.1.4.1. Blood

18.9.1.4.2. Nasal Swabs

18.9.1.4.3. Tissues

18.9.1.4.4. Saliva

18.9.1.4.5. Serum and Plasma

18.9.1.4.6. Stool

18.9.1.4.7. Cerebral Fluid

18.9.1.4.8. Others

18.9.1.5. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.1.5.1. cDNA Synthesis

18.9.1.5.2. Cloning

18.9.1.5.3. Real Time PCR

18.9.1.5.4. Microarray Analysis

18.9.1.5.5. Next-Generation Sequencing

18.9.1.5.6. Northern Blot Analysis

18.9.1.5.7. Pathogen Detection

18.9.1.5.8. Others

18.9.1.6. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.1.6.1. Hospitals

18.9.1.6.2. Laboratories

18.9.1.6.3. Others

18.9.1.7. Saudi Arabia DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.1.7.1. Direct

18.9.1.7.2. Indirect

18.9.2. UAE

18.9.2.1. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.2.1.1. Total RNA

18.9.2.1.2. Cell-free DNA

18.9.2.1.3. Viral DNA/RNA

18.9.2.1.4. Purified RNA

18.9.2.1.5. Sequence-Specific DNA/RNA

18.9.2.1.6. Others

18.9.2.2. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.2.2.1. Automated

18.9.2.2.2. Manual

18.9.2.3. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.2.3.1. Miniprep

18.9.2.3.2. Midiprep

18.9.2.3.3. Maxiprep

18.9.2.3.4. Others

18.9.2.4. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.2.4.1. Blood

18.9.2.4.2. Nasal Swabs

18.9.2.4.3. Tissues

18.9.2.4.4. Saliva

18.9.2.4.5. Serum and Plasma

18.9.2.4.6. Stool

18.9.2.4.7. Cerebral Fluid

18.9.2.4.8. Others

18.9.2.5. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.2.5.1. cDNA Synthesis

18.9.2.5.2. Cloning

18.9.2.5.3. Real Time PCR

18.9.2.5.4. Microarray Analysis

18.9.2.5.5. Next-Generation Sequencing

18.9.2.5.6. Northern Blot Analysis

18.9.2.5.7. Pathogen Detection

18.9.2.5.8. Others

18.9.2.6. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.2.6.1. Hospitals

18.9.2.6.2. Laboratories

18.9.2.6.3. Others

18.9.2.7. UAE DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.2.7.1. Direct

18.9.2.7.2. Indirect

18.9.3. Egypt

18.9.3.1. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.3.1.1. Total RNA

18.9.3.1.2. Cell-free DNA

18.9.3.1.3. Viral DNA/RNA

18.9.3.1.4. Purified RNA

18.9.3.1.5. Sequence-Specific DNA/RNA

18.9.3.1.6. Others

18.9.3.2. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.3.2.1. Automated

18.9.3.2.2. Manual

18.9.3.3. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.3.3.1. Miniprep

18.9.3.3.2. Midiprep

18.9.3.3.3. Maxiprep

18.9.3.3.4. Others

18.9.3.4. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.3.4.1. Blood

18.9.3.4.2. Nasal Swabs

18.9.3.4.3. Tissues

18.9.3.4.4. Saliva

18.9.3.4.5. Serum and Plasma

18.9.3.4.6. Stool

18.9.3.4.7. Cerebral Fluid

18.9.3.4.8. Others

18.9.3.5. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.3.5.1. cDNA Synthesis

18.9.3.5.2. Cloning

18.9.3.5.3. Real Time PCR

18.9.3.5.4. Microarray Analysis

18.9.3.5.5. Next-Generation Sequencing

18.9.3.5.6. Northern Blot Analysis

18.9.3.5.7. Pathogen Detection

18.9.3.5.8. Others

18.9.3.6. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.3.6.1. Hospitals

18.9.3.6.2. Laboratories

18.9.3.6.3. Others

18.9.3.7. Egypt DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.3.7.1. Direct

18.9.3.7.2. Indirect

18.9.4. Kuwait

18.9.4.1. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.4.1.1. Total RNA

18.9.4.1.2. Cell-free DNA

18.9.4.1.3. Viral DNA/RNA

18.9.4.1.4. Purified RNA

18.9.4.1.5. Sequence-Specific DNA/RNA

18.9.4.1.6. Others

18.9.4.2. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.4.2.1. Automated

18.9.4.2.2. Manual

18.9.4.3. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.4.3.1. Miniprep

18.9.4.3.2. Midiprep

18.9.4.3.3. Maxiprep

18.9.4.3.4. Others

18.9.4.4. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.4.4.1. Blood

18.9.4.4.2. Nasal Swabs

18.9.4.4.3. Tissues

18.9.4.4.4. Saliva

18.9.4.4.5. Serum and Plasma

18.9.4.4.6. Stool

18.9.4.4.7. Cerebral Fluid

18.9.4.4.8. Others

18.9.4.5. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.4.5.1. cDNA Synthesis

18.9.4.5.2. Cloning

18.9.4.5.3. Real Time PCR

18.9.4.5.4. Microarray Analysis

18.9.4.5.5. Next-Generation Sequencing

18.9.4.5.6. Northern Blot Analysis

18.9.4.5.7. Pathogen Detection

18.9.4.5.8. Others

18.9.4.6. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.4.6.1. Hospitals

18.9.4.6.2. Laboratories

18.9.4.6.3. Others

18.9.4.7. Kuwait DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.4.7.1. Direct

18.9.4.7.2. Indirect

18.9.5. South Africa

18.9.5.1. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.5.1.1. Total RNA

18.9.5.1.2. Cell-free DNA

18.9.5.1.3. Viral DNA/RNA

18.9.5.1.4. Purified RNA

18.9.5.1.5. Sequence-Specific DNA/RNA

18.9.5.1.6. Others

18.9.5.2. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.5.2.1. Automated

18.9.5.2.2. Manual

18.9.5.3. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.5.3.1. Miniprep

18.9.5.3.2. Midiprep

18.9.5.3.3. Maxiprep

18.9.5.3.4. Others

18.9.5.4. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.5.4.1. Blood

18.9.5.4.2. Nasal Swabs

18.9.5.4.3. Tissues

18.9.5.4.4. Saliva

18.9.5.4.5. Serum and Plasma

18.9.5.4.6. Stool

18.9.5.4.7. Cerebral Fluid

18.9.5.4.8. Others

18.9.5.5. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.5.5.1. cDNA Synthesis

18.9.5.5.2. Cloning

18.9.5.5.3. Real Time PCR

18.9.5.5.4. Microarray Analysis

18.9.5.5.5. Next-Generation Sequencing

18.9.5.5.6. Northern Blot Analysis

18.9.5.5.7. Pathogen Detection

18.9.5.5.8. Others

18.9.5.6. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.5.6.1. Hospitals

18.9.5.6.2. Laboratories

18.9.5.6.3. Others

18.9.5.7. South Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.5.7.1. Direct

18.9.5.7.2. Indirect

18.9.6. Rest of Middle East & Africa

18.9.6.1. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

18.9.6.1.1. Total RNA

18.9.6.1.2. Cell-free DNA

18.9.6.1.3. Viral DNA/RNA

18.9.6.1.4. Purified RNA

18.9.6.1.5. Sequence-Specific DNA/RNA

18.9.6.1.6. Others

18.9.6.2. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

18.9.6.2.1. Automated

18.9.6.2.2. Manual

18.9.6.3. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

18.9.6.3.1. Miniprep

18.9.6.3.2. Midiprep

18.9.6.3.3. Maxiprep

18.9.6.3.4. Others

18.9.6.4. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

18.9.6.4.1. Blood

18.9.6.4.2. Nasal Swabs

18.9.6.4.3. Tissues

18.9.6.4.4. Saliva

18.9.6.4.5. Serum and Plasma

18.9.6.4.6. Stool

18.9.6.4.7. Cerebral Fluid

18.9.6.4.8. Others

18.9.6.5. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

18.9.6.5.1. cDNA Synthesis

18.9.6.5.2. Cloning

18.9.6.5.3. Real Time PCR

18.9.6.5.4. Microarray Analysis

18.9.6.5.5. Next-Generation Sequencing

18.9.6.5.6. Northern Blot Analysis

18.9.6.5.7. Pathogen Detection

18.9.6.5.8. Others

18.9.6.6. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

18.9.6.6.1. Hospitals

18.9.6.6.2. Laboratories

18.9.6.6.3. Others

18.9.6.7. Rest of Middle East & Africa DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

18.9.6.7.1. Direct

18.9.6.7.2. Indirect

18.10. Key Segment for Channeling Investments

18.10.1. By Country

18.10.2. By Type

18.10.3. By Format

18.10.4. By Kit Size

18.10.5. By Sample Type

18.10.6. By Application

18.10.7. By End User

18.10.8. By Sales Channel

19. Latin America DNA/RNA Extraction Kit Market Analysis and Forecasts, 2019 - 2027

19.1. Overview

19.1.1. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn)

19.2. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

19.2.1. Total RNA

19.2.2. Cell-free DNA

19.2.3. Viral DNA/RNA

19.2.4. Purified RNA

19.2.5. Sequence-Specific DNA/RNA

19.2.6. Others

19.3. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

19.3.1. Automated

19.3.2. Manual

19.4. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

19.4.1. Miniprep

19.4.2. Midiprep

19.4.3. Maxiprep

19.4.4. Others

19.5. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

19.5.1. Blood

19.5.2. Nasal Swabs

19.5.3. Tissues

19.5.4. Saliva

19.5.5. Serum and Plasma

19.5.6. Stool

19.5.7. Cerebral Fluid

19.5.8. Others

19.6. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

19.6.1. cDNA Synthesis

19.6.2. Cloning

19.6.3. Real Time PCR

19.6.4. Microarray Analysis

19.6.5. Next-Generation Sequencing

19.6.6. Northern Blot Analysis

19.6.7. Pathogen Detection

19.6.8. Others

19.7. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

19.7.1. Hospitals

19.7.2. Laboratories

19.7.3. Others

19.8. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

19.8.1. Direct

19.8.2. Indirect

19.9. Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Country

19.9.1. Brazil

19.9.1.1. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

19.9.1.1.1. Total RNA

19.9.1.1.2. Cell-free DNA

19.9.1.1.3. Viral DNA/RNA

19.9.1.1.4. Purified RNA

19.9.1.1.5. Sequence-Specific DNA/RNA

19.9.1.1.6. Others

19.9.1.2. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

19.9.1.2.1. Automated

19.9.1.2.2. Manual

19.9.1.3. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

19.9.1.3.1. Miniprep

19.9.1.3.2. Midiprep

19.9.1.3.3. Maxiprep

19.9.1.3.4. Others

19.9.1.4. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

19.9.1.4.1. Blood

19.9.1.4.2. Nasal Swabs

19.9.1.4.3. Tissues

19.9.1.4.4. Saliva

19.9.1.4.5. Serum and Plasma

19.9.1.4.6. Stool

19.9.1.4.7. Cerebral Fluid

19.9.1.4.8. Others

19.9.1.5. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

19.9.1.5.1. cDNA Synthesis

19.9.1.5.2. Cloning

19.9.1.5.3. Real Time PCR

19.9.1.5.4. Microarray Analysis

19.9.1.5.5. Next-Generation Sequencing

19.9.1.5.6. Northern Blot Analysis

19.9.1.5.7. Pathogen Detection

19.9.1.5.8. Others

19.9.1.6. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

19.9.1.6.1. Hospitals

19.9.1.6.2. Laboratories

19.9.1.6.3. Others

19.9.1.7. Brazil DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

19.9.1.7.1. Direct

19.9.1.7.2. Indirect

19.9.2. Argentina

19.9.2.1. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

19.9.2.1.1. Total RNA

19.9.2.1.2. Cell-free DNA

19.9.2.1.3. Viral DNA/RNA

19.9.2.1.4. Purified RNA

19.9.2.1.5. Sequence-Specific DNA/RNA

19.9.2.1.6. Others

19.9.2.2. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

19.9.2.2.1. Automated

19.9.2.2.2. Manual

19.9.2.3. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

19.9.2.3.1. Miniprep

19.9.2.3.2. Midiprep

19.9.2.3.3. Maxiprep

19.9.2.3.4. Others

19.9.2.4. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

19.9.2.4.1. Blood

19.9.2.4.2. Nasal Swabs

19.9.2.4.3. Tissues

19.9.2.4.4. Saliva

19.9.2.4.5. Serum and Plasma

19.9.2.4.6. Stool

19.9.2.4.7. Cerebral Fluid

19.9.2.4.8. Others

19.9.2.5. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

19.9.2.5.1. cDNA Synthesis

19.9.2.5.2. Cloning

19.9.2.5.3. Real Time PCR

19.9.2.5.4. Microarray Analysis

19.9.2.5.5. Next-Generation Sequencing

19.9.2.5.6. Northern Blot Analysis

19.9.2.5.7. Pathogen Detection

19.9.2.5.8. Others

19.9.2.6. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

19.9.2.6.1. Hospitals

19.9.2.6.2. Laboratories

19.9.2.6.3. Others

19.9.2.7. Argentina DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

19.9.2.7.1. Direct

19.9.2.7.2. Indirect

19.9.3. Rest of Latin America

19.9.3.1. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Type

19.9.3.1.1. Total RNA

19.9.3.1.2. Cell-free DNA

19.9.3.1.3. Viral DNA/RNA

19.9.3.1.4. Purified RNA

19.9.3.1.5. Sequence-Specific DNA/RNA

19.9.3.1.6. Others

19.9.3.2. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Format

19.9.3.2.1. Automated

19.9.3.2.2. Manual

19.9.3.3. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Kit Size

19.9.3.3.1. Miniprep

19.9.3.3.2. Midiprep

19.9.3.3.3. Maxiprep

19.9.3.3.4. Others

19.9.3.4. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sample Type

19.9.3.4.1. Blood

19.9.3.4.2. Nasal Swabs

19.9.3.4.3. Tissues

19.9.3.4.4. Saliva

19.9.3.4.5. Serum and Plasma

19.9.3.4.6. Stool

19.9.3.4.7. Cerebral Fluid

19.9.3.4.8. Others

19.9.3.5. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Application

19.9.3.5.1. cDNA Synthesis

19.9.3.5.2. Cloning

19.9.3.5.3. Real Time PCR

19.9.3.5.4. Microarray Analysis

19.9.3.5.5. Next-Generation Sequencing

19.9.3.5.6. Northern Blot Analysis

19.9.3.5.7. Pathogen Detection

19.9.3.5.8. Others

19.9.3.6. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By End User

19.9.3.6.1. Hospitals

19.9.3.6.2. Laboratories

19.9.3.6.3. Others

19.9.3.7. Rest of Latin America DNA/RNA Extraction Kit Market Revenue (US$ Mn) and Forecasts, By Sales Channel

19.9.3.7.1. Direct

19.9.3.7.2. Indirect

19.10. Key Segment for Channeling Investments

19.10.1. By Country

19.10.2. By Type

19.10.3. By Format

19.10.4. By Kit Size

19.10.5. By Sample Type

19.10.6. By Application

19.10.7. By End User

19.10.8. By Sales Channel

20. Competitive Benchmarking

20.1. Market Share Analysis, 2018

20.2. Global Presence and Growth Strategies

20.2.1. Mergers and Acquisitions

20.2.2. Product Launches

20.2.3. Investments Trends

20.2.4. R&D Initiatives

21. Player Profiles

21.1. Agilent Technologies, Inc.

21.1.1. Company Details

21.1.2. Company Overview

21.1.3. Product Offerings

21.1.4. Key Developments

21.1.5. Financial Analysis

21.1.6. SWOT Analysis

21.1.7. Business Strategies

21.2. Akonni Biosystems, Inc.

21.2.1. Company Details

21.2.2. Company Overview

21.2.3. Product Offerings

21.2.4. Key Developments

21.2.5. Financial Analysis

21.2.6. SWOT Analysis

21.2.7. Business Strategies

21.3. Beckman Coulter, Inc

21.3.1. Company Details

21.3.2. Company Overview

21.3.3. Product Offerings

21.3.4. Key Developments

21.3.5. Financial Analysis

21.3.6. SWOT Analysis

21.3.7. Business Strategies

21.4. BIOFIRE DIAGONOSTIC, INC.

21.4.1. Company Details

21.4.2. Company Overview

21.4.3. Product Offerings

21.4.4. Key Developments

21.4.5. Financial Analysis

21.4.6. SWOT Analysis

21.4.7. Business Strategies

21.5. Bioneer Corporation

21.5.1. Company Details

21.5.2. Company Overview

21.5.3. Product Offerings

21.5.4. Key Developments

21.5.5. Financial Analysis

21.5.6. SWOT Analysis

21.5.7. Business Strategies

21.6. Bio-Rad Laboratories, Inc.

21.6.1. Company Details

21.6.2. Company Overview

21.6.3. Product Offerings

21.6.4. Key Developments

21.6.5. Financial Analysis

21.6.6. SWOT Analysis

21.6.7. Business Strategies

21.7. Canvax Biotech S.L.

21.7.1. Company Details

21.7.2. Company Overview

21.7.3. Product Offerings

21.7.4. Key Developments

21.7.5. Financial Analysis

21.7.6. SWOT Analysis

21.7.7. Business Strategies

21.8. Hunan Runmei Gene Technology Co.,LTD

21.8.1. Company Details

21.8.2. Company Overview

21.8.3. Product Offerings

21.8.4. Key Developments

21.8.5. Financial Analysis

21.8.6. SWOT Analysis

21.8.7. Business Strategies

21.9. Krishgen Biosystems.

21.9.1. Company Details

21.9.2. Company Overview

21.9.3. Product Offerings

21.9.4. Key Developments

21.9.5. Financial Analysis

21.9.6. SWOT Analysis

21.9.7. Business Strategies

21.10. Lexogen GmbH

21.10.1. Company Details

21.10.2. Company Overview

21.10.3. Product Offerings

21.10.4. Key Developments

21.10.5. Financial Analysis

21.10.6. SWOT Analysis

21.10.7. Business Strategies

21.11. Primerdesign Ltd

21.11.1. Company Details

21.11.2. Company Overview

21.11.3. Product Offerings

21.11.4. Key Developments

21.11.5. Financial Analysis

21.11.6. SWOT Analysis

21.11.7. Business Strategies

21.12. Promega Corporation.

21.12.1. Company Details

21.12.2. Company Overview

21.12.3. Product Offerings

21.12.4. Key Developments

21.12.5. Financial Analysis

21.12.6. SWOT Analysis

21.12.7. Business Strategies

21.13. QIAGEN

21.13.1. Company Details

21.13.2. Company Overview

21.13.3. Product Offerings

21.13.4. Key Developments

21.13.5. Financial Analysis

21.13.6. SWOT Analysis

21.13.7. Business Strategies

21.14. Swagene

21.14.1. Company Details

21.14.2. Company Overview

21.14.3. Product Offerings

21.14.4. Key Developments

21.14.5. Financial Analysis

21.14.6. SWOT Analysis

21.14.7. Business Strategies

21.15. TaigenBioscience Corporation

21.15.1. Company Details

21.15.2. Company Overview

21.15.3. Product Offerings

21.15.4. Key Developments

21.15.5. Financial Analysis

21.15.6. SWOT Analysis

21.15.7. Business Strategies

21.16. Takara Bio Inc

21.16.1. Company Details

21.16.2. Company Overview

21.16.3. Product Offerings

21.16.4. Key Developments

21.16.5. Financial Analysis

21.16.6. SWOT Analysis

21.16.7. Business Strategies

21.17. Thermo Fisher Scientific Inc.

21.17.1. Company Details

21.17.2. Company Overview

21.17.3. Product Offerings

21.17.4. Key Developments

21.17.5. Financial Analysis

21.17.6. SWOT Analysis

21.17.7. Business Strategies

21.18. Other Market Participants

22. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $3300

Multi users $6600

Global users $7300

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com